Jagan Billakanti
Dr. Jagan Billakanti is an accomplished Bioprocess Scientist with over 17 years of combined experience across the biopharmaceuticals, biologics development, and food and beverage industries. Currently serving as the Genomic Medicine Workflow Development Leader at Cytiva ANZ, Jagan plays a key role in driving innovation in workflow design and scalable solutions for advanced therapeutics.
He earned his Ph.D. in Chemical and Process Engineering from the University of Canterbury, New Zealand in 2009. Dr. Billakanti has published over 20 peer-reviewed journal articles, received more than 500 citations, and presented at over 20 scientific conferences.
Jagan brings deep technical expertise in the development, scale-up, and manufacturing of APIs and bulk biological drugs. He has a proven track record of delivering translational, commercial, and contract manufacturing projects on time and within budget.
His core strengths include end-to-end workflow design, product lifecycle strategy, and process development for a range of modalities including:
Cell and Gene Therapy
Viral Vectors (AAV, LV, Exosomes)
RNA Platforms (mRNA, saRNA, siRNA, sgRNA, Oligonucleotides)
Lipid Nanoparticles (LNPs)
Monoclonal Antibodies & Recombinant Proteins
High-value natural proteins from dairy, agriculture, and aquaculture sources
He is well-versed in regulatory and quality frameworks, including GMP, GLP, FDA, TGA, HACCP, and regional standards across ANZ and GB.
With strong communication skills and a collaborative approach, Dr. Billakanti effectively engages with cross-functional teams, bridging technical and business objectives to support innovative product development and commercialization.
https://www.linkedin.com/in/dr-jagan-billakanti-7123984/
Abstracts this author is presenting: